India will become the largest global hub for Covid-19 antiviral general drug production after the drug controller granted emergency-use authorisation to several pharmaceutical companies in the country to manufacture and…
New Delhi: Following the results obtained from clinical trials, ChemRar Group announced that the Russian version of globally recognised drug Favipiravir, Avifavir, is highly effective against various variants of COVID…
MSD and Ridgeback Biotherapeutics on Friday said its potential antiviral COVID-19 drug molnupiravir reduced the relative risk of hospitalization or death by 30% compared to placebo group. The analysis of…
LUCKNOW: The Central Drug Research Institute (CDRI) on Tuesday claimed that the clinical trials of antiviral drug, Umifenovir, in treatment of Covid-19 have been successful. The trial of Umifenovir on…
